Home > Compound List > Compound details
10338-51-9 molecular structure
click picture or here to close

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[2-(4-hydroxyphenyl)ethoxy]oxane-3,4,5-triol

ChemBase ID: 73016
Molecular Formular: C14H20O7
Molecular Mass: 300.3044
Monoisotopic Mass: 300.12090298
SMILES and InChIs

SMILES:
[C@H]1([C@H]([C@@H]([C@H]([C@@H](O1)OCCc1ccc(cc1)O)O)O)O)CO
Canonical SMILES:
OC[C@H]1O[C@@H](OCCc2ccc(cc2)O)[C@@H]([C@H]([C@@H]1O)O)O
InChI:
InChI=1S/C14H20O7/c15-7-10-11(17)12(18)13(19)14(21-10)20-6-5-8-1-3-9(16)4-2-8/h1-4,10-19H,5-7H2/t10-,11-,12+,13-,14-/m1/s1
InChIKey:
ILRCGYURZSFMEG-RKQHYHRCSA-N

Cite this record

CBID:73016 http://www.chembase.cn/molecule-73016.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[2-(4-hydroxyphenyl)ethoxy]oxane-3,4,5-triol
IUPAC Traditional name
salidroside
Synonyms
Rhodioloside
Salidroside(Rhodioloside)
CAS Number
10338-51-9
PubChem SID
162037936
PubChem CID
159278

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID Price
Selleck Chemicals
S2396 external link Add to cart Please log in.
Data Source Data ID
PubChem 159278 external link

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 10.198019  H Acceptors
H Donor LogD (pH = 5.5) -0.57985234 
LogD (pH = 7.4) -0.5805308  Log P -0.5798437 
Molar Refractivity 72.0231 cm3 Polarizability 28.860756 Å3
Polar Surface Area 119.61 Å2 Rotatable Bonds
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Safety Information Product Information Bioassay(PubChem)
Storage Condition
-20°C expand Show data source
Salt Data
Free Base expand Show data source

DETAILS

DETAILS

Selleck Chemicals Selleck Chemicals
Selleck Chemicals - S2396 external link
Research Area: Cancer
Biological Activity:
Salidroside (Rhodioloside; Rhodosin) is a glucoside compound with an IC50 of 4.99 ± 0.23 μg/mL for the proliferation of SACC-2. Salidroside (Rhodioloside; Rhodosin) could inhibit the proliferation of SACC-2 cells and induce SACC-2 cell apoptosis in vitro, which could be a kind of antitumor medicine in the future. Growing curve showed that SACC-2 cells of salidroside groups decreased with extending cell culture time. Immunohistochemistry staining showed that Caspase 3 and Caspase 8 were both strong positive expression in SACC-2 cells of salidroside groups, and poor positive expression in SACC-2 cells of control group, the difference was significant (P<0.01).Salidroside (Rhodioloside; Rhodosin) induces cell-cycle arrest and apoptosis in human breast cancer cells and may be a promising candidate for breast cancer treatment. [1][2][3]

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • Hu X et al. Biochem Biophys Res Commun. 2010 Jul 16;398(1):62-7.
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle